Mismatch repair deficiency, a future biomarker to guide adjuvant chemotherapy in localized small bowel adenocarcinoma?

We thank Vanoli et  al. for the study “Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: a multicentric international study” [1].

Source: Digestive and Liver Disease - July 7, 2023 Category: Gastroenterology Authors: Anthony Turpin Tags: Commentary Source Type: research